Sphera Funds Management LTD. purchased a new position in shares of Arvinas Inc (NASDAQ:ARVN) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 240,000 shares of the company’s stock, valued at approximately $4,049,000.

Other large investors have also modified their holdings of the company. Gilder Gagnon Howe & Co. LLC purchased a new stake in shares of Arvinas during the third quarter worth approximately $129,000. Citadel Advisors LLC purchased a new stake in shares of Arvinas during the third quarter worth approximately $463,000. Birchview Capital LP purchased a new stake in shares of Arvinas during the third quarter worth approximately $506,000. Dean Capital Investments Management LLC purchased a new stake in shares of Arvinas during the third quarter worth approximately $631,000. Finally, Monashee Investment Management LLC purchased a new stake in shares of Arvinas during the third quarter worth approximately $2,024,000. Institutional investors own 41.89% of the company’s stock.

A number of analysts recently weighed in on the stock. Citigroup assumed coverage on shares of Arvinas in a research note on Monday, October 22nd. They set a “buy” rating and a $21.00 target price on the stock. Piper Jaffray Companies assumed coverage on shares of Arvinas in a research note on Monday, October 22nd. They set an “overweight” rating and a $23.00 target price on the stock. Finally, Goldman Sachs Group assumed coverage on shares of Arvinas in a research note on Monday, October 22nd. They set a “neutral” rating and a $17.00 target price on the stock.

In related news, insider James E. Flynn purchased 312,500 shares of the company’s stock in a transaction on Monday, October 1st. The shares were bought at an average cost of $16.00 per share, for a total transaction of $5,000,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bradley Albert Margus purchased 40,000 shares of the company’s stock in a transaction on Monday, October 1st. The stock was bought at an average price of $16.00 per share, for a total transaction of $640,000.00. The disclosure for this purchase can be found here. Insiders have purchased 354,100 shares of company stock worth $5,665,600 over the last 90 days.

ARVN stock opened at $16.59 on Friday. Arvinas Inc has a fifty-two week low of $13.70 and a fifty-two week high of $21.25.

WARNING: “240,000 Shares in Arvinas Inc (ARVN) Purchased by Sphera Funds Management LTD.” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.dailypolitical.com/2018/12/08/240000-shares-in-arvinas-inc-arvn-purchased-by-sphera-funds-management-ltd.html.

About Arvinas

Arvinas Holding Company, LLC, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer.

See Also: What is the Ex-Dividend Date in Investing?

Want to see what other hedge funds are holding ARVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arvinas Inc (NASDAQ:ARVN).

Institutional Ownership by Quarter for Arvinas (NASDAQ:ARVN)

Receive News & Ratings for Arvinas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arvinas and related companies with MarketBeat.com's FREE daily email newsletter.